Hems ( India ) Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Hems ( India ) Pharmaceutical Export Portfolio Dataset — 2 Products, $51.7K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Hems ( India ) — Pharmaceutical Exporter Profile (2026) | 2 Products, $51.7K Trade | TransData Nexus

Product Portfolio — Top 2 by Export Value

Hems ( India ) exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Brufen	Brand Names & OTC Products	$45.5K	4	1.0%	6
2	Neosporin	Brand Names & OTC Products	$6.2K	4	6.2%	6

Hems ( India ) exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $51.7K. The top category is Brand Names & OTC Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Hems ( India ) — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

Hems India, established in 1986, is a government-recognized Star Export House headquartered in Chennai, Tamil Nadu, India. The company specializes in the export of pharmaceutical and surgical products, serving international health ministries and private organizations across countries such as the Maldives, Myanmar, Seychelles, Somalia, Côte d'Ivoire, and Papua New Guinea.

As a small enterprise under the MSME classification, Hems India operates with a focus on providing high-quality, reliable, and timely delivery of medical supplies. The company's product portfolio includes generic and branded medicines, insulin products, medical disposables, surgical instruments, oncology and critical care medicines, and life-saving drugs.

2Manufacturing Facilities

Hems India sources its pharmaceutical and surgical products from reputed and certified Indian and international manufacturers. While specific details about the company's own manufacturing facilities are not publicly disclosed, the emphasis on sourcing from certified manufacturers ensures compliance with international quality standards.

3Key Leadership

The leadership team at Hems India comprises individuals with extensive experience in the pharmaceutical export sector. The company's founder and key executive is Hemraj, who has been instrumental in establishing and expanding Hems India's global presence.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Hems ( India ) Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Hems India exports pharmaceutical products to various international markets, including the Maldives, Myanmar, Seychelles, Somalia, Côte d'Ivoire, and Papua New Guinea. While specific regulatory approvals for these markets are not detailed, the company's recognition as a Star Export House indicates adherence to international trade and regulatory standards.

2Emerging Markets

Hems India's export strategy includes penetration into emerging markets such as Africa, Latin America, and Southeast Asia. The company's focus on providing life-saving medicines and critical care products aligns with the healthcare needs of these regions. However, specific details regarding WHO prequalification or other certifications enabling access to these markets are not publicly available.

3Geographic Strategy

Hems India's export strategy demonstrates a diversified approach, targeting multiple international markets across different continents. This diversification helps mitigate concentration risk and positions the company to leverage growth opportunities in various regions. The strategic direction appears to focus on expanding the company's global footprint by catering to diverse healthcare needs.

Hems ( India ) — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Hems India's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history is not publicly available. The company's export activities primarily target markets such as the Maldives, Myanmar, Seychelles, Somalia, Côte d'Ivoire, and Papua New Guinea, where FDA approvals may not be a regulatory requirement.

2WHO & EU GMP

Details about Hems India's WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, or European Directorate for the Quality of Medicines (EDQM) status are not publicly disclosed. The company's focus on exporting to countries like the Maldives, Myanmar, Seychelles, Somalia, Côte d'Ivoire, and Papua New Guinea suggests that such certifications may not be mandatory for market access in these regions.

3CDSCO & Indian Regulatory

Hems India operates under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) in India. The company holds the necessary manufacturing licenses and approvals from state drug controllers to export pharmaceutical products. Specific details regarding export No Objection Certificates (NOCs) are not publicly available.

Hems ( India ) — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Hems India operates in a competitive landscape with several key players in the pharmaceutical export sector. While specific market share data is not publicly available, the company's focus on providing a diverse range of pharmaceutical and surgical products positions it to compete effectively in the global market. The emphasis on timely delivery, secure packaging, and hassle-free documentation further enhances its competitive edge.

2Key Differentiators

Hems India's key differentiators include its extensive experience of over 40 years in the pharmaceutical export industry, a diverse product portfolio encompassing generic and branded medicines, insulin products, medical disposables, surgical instruments, oncology and critical care medicines, and life-saving drugs. The company's commitment to swift and reliable delivery, secure packaging, and hassle-free documentation further distinguishes it in the market.

3Strategic Position

Hems India currently focuses on exporting a wide range of pharmaceutical and surgical products, including generic and branded medicines, insulin products, medical disposables, surgical instruments, oncology and critical care medicines, and life-saving drugs. The company's strategic direction appears to be centered on expanding its global presence by catering to diverse healthcare needs across various international markets. Future outlooks may involve enhancing product offerings, obtaining additional certifications, and exploring new market opportunities to strengthen its position in the global pharmaceutical export sector.

Buyer Due Diligence Brief — Evaluating Hems ( India ) as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Hems India demonstrates a strong track record in exporting pharmaceutical and surgical products, with a total export value of $52,000 USD across 8 shipments. The company's portfolio is concentrated on two products: Brufen, with an export value of $46,000 USD and a market share of 1.0%, and Neosporin, with an export value of $6,000 USD and a market share of 6.2%. This concentration indicates a focused approach in its export strategy. The company's commitment to swift and reliable delivery, secure packaging, and hassle-free documentation further underscores its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications when considering Hems India as a supplier:

FDA Approval: To ensure compliance with U.S. regulatory standards.

WHO-GMP Certification: To confirm adherence to international manufacturing practices.

EU GMP Certification: To validate compliance with European manufacturing standards.

Frequently Asked Questions — Hems ( India )

How many pharmaceutical products does Hems ( India ) export from India?

Hems ( India ) exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Brufen ($45.5K), Neosporin ($6.2K). Total export value is $51.7K.

What is Hems ( India )'s total pharmaceutical export value?

Hems ( India )'s total pharmaceutical export value is $51.7K, based on 8 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Hems ( India ) cover?

Hems ( India ) exports across 1 therapeutic categories. The largest are Brand Names & OTC Products (100.0%, 2 products).

Get Full Hems ( India ) Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.

Hems ( India )

Hems ( India ) — Export Portfolio & Destination Treemap

Who is Hems ( India )? — Company Overview & Market Position

What Does Hems ( India ) Export? — Product Portfolio Analysis

Top Products by Export Value

Hems ( India ) Therapeutic Categories — 1 Specializations